John
Chan
Head, ShinrAI Center for Artificial Intelligence & Machine Learning
Takeda
John is a technology executive, trained as a scientist and an engineer, with a 25-year career in data sciences. During this time, he built and led computational teams and pioneered innovation for global biopharma and biotech start-ups. He is now Head, ShinrAI Center for Artificial Intelligence and Machine Learning at Takeda. Prior to this, he built a computer vision-based AI company, Syllable Life Sciences, and as its CEO, led its acquisition by Neumora. Prior to his CEO role John held several management roles in computational biology, bioinformatics and enterprise IT, including time as an Executive Director and Head of Informatics, Technology and Program Innovation at Novartis. John earned a Ph.D. in genetics and molecular biology from the University of Pennsylvania.
19 October 2023 12:00 - 12:30
Panel discussion: Transforming healthcare with AI
Healthcare has been, and is being, completely revolutionized by digitization and AI/ML, with applications in everything from diagnosis and treatment to drug discovery and patient management. In this live podcast, Ahmed Serag (Novartis) will be joined by John Chan (Takeda), as they discuss some of the latest developments, and a look at how these changes are applicable cross-industry. This is an interactive session - bring your questions, and have your queries answered by two major leaders in their respective healthcare giants.